Submit Your Feeds

Business News • PR NewsWire • Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago® (safinamide) in Canada

Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago® (safinamide) in Canada
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago® (safinamide) in Canada

Valeo Pharma and Zambon announce a partnership in Canada which grants Valeo Pharma exclusive rights to commercialise Zambon's Parkinson's disease product, licensed from Newron New treatment option for estimated 100,000 Canadians living with Parkinson's disease Xadago®...

View More : http://www.prnewswire.com/news-releases/valeo-pharma-and-zambon-form-partnership-for-parkinsons-disease-treatment-xadago...
Releted News by prnewswire
CORRECTION - APAC Biotech Pvt. Ltd: Indian FDA Approves the First Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago® (safinamide) in Canada
Global Sources Electronics show opens today with 6,200 booths in two phases
Home Sitemap Contact Us
© businessNewsNewsNews.com